Suzdak PD - Search Results

1

Characterization of novel ligands for wild-type and natural mutant diazepam-insensitive benzodiazepine receptors.

Wong G, Uusi-Oukari M, Hansen HC, Suzdak PD, Korpi ER. Wong G, et al. Among authors: suzdak pd. Eur J Pharmacol. 1995 Apr 28;289(2):335-42. doi: 10.1016/0922-4106(95)90111-6. Eur J Pharmacol. 1995. PMID: 7621907

2

Cerebellar GABAA receptors in two rat lines selected for high and low sensitivity to moderate alcohol doses: pharmacological and genetic studies.

Korpi ER, Uusi-Oukari M, Castren E, Suzdak PD, Seppälä T, Sarviharju M, Tuominen K. Korpi ER, et al. Among authors: suzdak pd. Alcohol. 1992 May-Jun;9(3):225-31. doi: 10.1016/0741-8329(92)90058-i. Alcohol. 1992. PMID: 1318723

3

Mechanisms of alcohol intoxication in a rodent model: blunted alcohol-opposing reaction in "alcohol-sensitive" rats.

Korpi ER, Tuominen K, Uusi-Oukari M, Saransaari P, Oja SS, Suzdak PD. Korpi ER, et al. Among authors: suzdak pd. Ann Med. 1990;22(4):253-8. doi: 10.3109/07853899009148936. Ann Med. 1990. PMID: 2248761 Free article.

4

Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.

Jackson HC, Hansen HC, Kristiansen M, Suzdak PD, Klitgaard H, Judge ME, Swedberg MD. Jackson HC, et al. Among authors: suzdak pd. Eur J Pharmacol. 1996 Jul 11;308(1):21-30. doi: 10.1016/0014-2999(96)00263-4. Eur J Pharmacol. 1996. PMID: 8836628

5

Ethanol and the GABA receptor complex: studies with the partial inverse benzodiazepine receptor agonist Ro 15-4513.

Glowa JR, Crawley J, Suzdak PD, Paul SM. Glowa JR, et al. Among authors: suzdak pd. Pharmacol Biochem Behav. 1988 Nov;31(3):767-72. doi: 10.1016/0091-3057(88)90263-8. Pharmacol Biochem Behav. 1988. PMID: 2855121

6

Effects of Ro15-4513 and other benzodiazepine receptor inverse agonists on alcohol-induced intoxication in the rat.

Suzdak PD, Paul SM, Crawley JN. Suzdak PD, et al. J Pharmacol Exp Ther. 1988 Jun;245(3):880-6. J Pharmacol Exp Ther. 1988. PMID: 2455039

7

NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization.

Suzdak PD, Frederiksen K, Andersen KE, Sørensen PO, Knutsen LJ, Nielsen EB. Suzdak PD, et al. Eur J Pharmacol. 1992 Dec 2;224(2-3):189-98. doi: 10.1016/0014-2999(92)90804-d. Eur J Pharmacol. 1992. PMID: 1468507

8

Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family.

Thomsen C, Boel E, Suzdak PD. Thomsen C, et al. Among authors: suzdak pd. Eur J Pharmacol. 1994 Mar 15;267(1):77-84. doi: 10.1016/0922-4106(94)90227-5. Eur J Pharmacol. 1994. PMID: 7515823

9

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.

Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJ, Sonnewald U, Braestrup C. Nielsen EB, et al. Among authors: suzdak pd. Eur J Pharmacol. 1991 Apr 24;196(3):257-66. doi: 10.1016/0014-2999(91)90438-v. Eur J Pharmacol. 1991. PMID: 1832636

10

Characterization of the metabotropic glutamate receptor in mouse cerebellar granule cells: lack of effect of 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (NBQX).

Suzdak PD, Sheardown MJ, Honoré T. Suzdak PD, et al. Eur J Pharmacol. 1993 May 15;245(3):215-20. doi: 10.1016/0922-4106(93)90099-u. Eur J Pharmacol. 1993. PMID: 7687559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters